Navigation Links
Premier Research Announces Completion of Management Buyout

LONDON, June 10 /PRNewswire/ -- Premier Research Group plc, the international pharmaceutical services company, announces the completion of its previously announced management buyout. As a result, the company is no longer listed on the AIM market of the London Stock Exchange. The UK-based private equity firm ECI Partners provided funding for the transaction.

Said Dr. Simon Yaxley, Chief Executive Officer of Premier Research Group, "This event ensures that we are able to continue our thoughtful and measured 'buy-and-build' strategy to allow us to continue to deliver exceptional quality and service to our clients around the world." Dr. Yaxley continued, "Further, we are pleased to announce that our existing management team remains fully intact, and is as dedicated as ever to ensuring our clients' expectations are met or exceeded. As a result, our clients, both existing and prospective, will not experience any visible change in working with the Premier Research team."

Mr. Richard Chapman of ECI Partners commented, "We are extremely pleased to have concluded this important transaction. We have long been interested in the CRO sector, and are excited to have found a successful and growing company such as Premier Research in which to invest. Our comprehensive due diligence confirmed our belief that Premier Research is a company of the highest quality with an exceptional future in providing clinical research services to global pharmaceutical, biotechnology, and medical device companies. We are also pleased that the existing management team remains committed to the long-term success of the business."

About Premier Research

Premier Research is a leading solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for Analgesia, CNS, Infectious Disease, and Oncology and have a wealth of experience in medical device and pediatric research.

Premier Research has 30 offices and operates in more than 30 countries across Europe and North America. Premier Research employs more than 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

SOURCE Premier Research Group plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety
2. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
3. Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
4. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
5. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
6. Premier Research Appoints Global Head of Human Resources
7. Premier Research Appoints Melissa Jones as Vice President, International Business Development
8. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
9. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
10. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd.
Post Your Comments:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
Breaking Biology Technology:
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):